LRP1 and metabolic dysfunction-associated steatotic liver disease: The role of NAFLD in AD has been further substantiated by recent studies in murine models of AD, where induction of NAFLD accelerated pathological AD signs such as neuroinflammation, cerebral hypoperfusion, reduced expression of brain LRP-1, and dysregulation of amyloid β metabolism [64,136].